FRANKFURT, Aug 9 - BioNTech and partner Pfizer added more than one billion doses of their COVID-19 vaccine as per July 21 — a bigger number than the supplied by competitor AstraZeneca, the German biotech group said on Monday.
AstraZeneca said on July 29 that it was and its manufacturing partner, India-based Serum Institute, supplied a billion doses to 170 countries at the time.
Based on the contracts so far, BioNTech said in a statement it expects 15.9 billion Euros of revenue from the vaccine this year, up from a projection of 12.4 billion euros in May.
It includes sales, milestone payments from partners and a share of gross income in its partners’ territories, the company added.